Bharat Serums AND Vaccines Limited — Serum Exporter Profile
Indian Pharmaceutical Exporter · #1 for Serum · $6.5M export value · DGFT Verified
Bharat Serums AND Vaccines Limited is the #1 Indian exporter of Serum with $6.5M in export value and 131 verified shipments. Bharat Serums AND Vaccines Limited holds a 24.1% market share in Serum exports across 29 countries. The company exports 4 pharmaceutical products worth $40.1M across 3 therapeutic categories.
Bharat Serums AND Vaccines Limited — Serum Export Profile: Buyers & Destinations
Where Does Bharat Serums AND Vaccines Limited Export Serum?
| Country | Value | Shipments | Share |
|---|---|---|---|
| PHILIPPINES | $1.1M | 21 | 19.7% |
| ALGERIA | $750.0K | 21 | 14.1% |
| PAKISTAN | $695.3K | 16 | 13.0% |
| TUNISIA | $500.0K | 10 | 9.4% |
| SRI LANKA | $400.0K | 8 | 7.5% |
| MOROCCO | $334.2K | 9 | 6.3% |
| THAILAND | $250.1K | 8 | 4.7% |
| MYANMAR | $218.0K | 13 | 4.1% |
| SOUTH AFRICA | $188.1K | 4 | 3.5% |
| TANZANIA | $168.8K | 5 | 3.2% |
Bharat Serums AND Vaccines Limited exports Serum to 33 countries. The largest destination is PHILIPPINES accounting for 19.7% of Bharat Serums AND Vaccines Limited's Serum shipments, followed by ALGERIA (14.1%) and PAKISTAN (13.0%). These destinations reflect Bharat Serums AND Vaccines Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Serum from Bharat Serums AND Vaccines Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| HABIB BANK LIMITED | PAKISTAN | $671.2K | 15 |
| PHARMACIE CENTRALE DE | TUNISIA | $400.0K | 8 |
| BSV BIOSCIENCE PHILS. INC | PHILIPPINES | $350.0K | 7 |
| INSTITUT PASTEUR DU MAROC | MOROCCO | $334.2K | 9 |
| INSTITUT PASTEUR D ALGERIE | ALGERIA | $300.0K | 8 |
| INSTITUT PASTEUR D?ALGERIE | ALGERIA | $250.0K | 8 |
| STATE PHARMACEUTICALS CORPORATION | SRI LANKA | $200.0K | 4 |
| BSV BIOSCIENCE PHILIPPINES INC | PHILIPPINES | $200.0K | 4 |
| BSV BIOSCIENCE PHILIPPHINES INC | PHILIPPINES | $200.0K | 4 |
| BGM PHARMACEUTICALS | SOUTH AFRICA | $188.1K | 4 |
Bharat Serums AND Vaccines Limited supplies Serum to 74 buyers globally. The largest buyer is HABIB BANK LIMITED (PAKISTAN), followed by PHARMACIE CENTRALE DE (TUNISIA) and BSV BIOSCIENCE PHILS. INC (PHILIPPINES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Serum Export Value and How Much Does Bharat Serums AND Vaccines Limited Contribute?
India exported $18.4M worth of Serum through 15,000 shipments from 341 suppliers to 122 countries, serving 897 buyers globally. Bharat Serums AND Vaccines Limited contributes $6.5M to this total, accounting for 24.1% of India's Serum exports. Bharat Serums AND Vaccines Limited ships Serum to 33 countries through 74 buyers.
What Is the Average Shipment Value for Bharat Serums AND Vaccines Limited's Serum Exports?
Bharat Serums AND Vaccines Limited's average Serum shipment value is $50.0K per consignment, based on 131 shipments totaling $6.5M. The largest destination is PHILIPPINES (19.7% of Bharat Serums AND Vaccines Limited's Serum exports).
How Does Bharat Serums AND Vaccines Limited Compare to Other Indian Serum Exporters?
Bharat Serums AND Vaccines Limited ranks #1 among 341 Indian Serum exporters with a 24.1% market share. The top 3 exporters are BHARAT SERUMS AND VACCINES LIMITED ($6.5M), VINS BIOPRODUCTS LIMITED ($5.7M), PREMIUM SERUMS AND VACCINES PRIVATE LIMITED ($1.4M). Bharat Serums AND Vaccines Limited processed 131 shipments to 29 destination countries.
What Serum Formulations Does Bharat Serums AND Vaccines Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| EQUIRAB 1000IU/5ML [Rabies Antiserum-Equ | $300.0K | 6 |
| EQUIRAB 1000IU/5ML [Rabies Antiserum - Equine] | $250.0K | 5 |
| EQUIRAB 1000 IU/5ML [ Rabies Antiserum -Equine] | $234.8K | 5 |
| EQUIRAB 1000 IU/ 5ML RABIES ANTISERUM - | $208.0K | 7 |
| EQUIRAB 1000 IU/5ML [RABIES ANTISERUM | $200.0K | 4 |
| EQUIRAB 1000 IU 5ML RABIES ANTISERUM EQUINE | $199.9K | 4 |
| EQUIRAB 1000 IU/5ML [ RABIES ANTISERUM -EQUINE] | $168.9K | 4 |
| EQUIRAB 1000 IU 5ML Rabies Antiserum Equine | $155.4K | 5 |
| EQUIRAB 1000IU 5ML Rabies Antiserum Equine | $150.0K | 3 |
| SNAKE VENOM ANTISERUM Lyophilized | $150.0K | 3 |
Bharat Serums AND Vaccines Limited exports 110 distinct Serum formulations including tablets, capsules, syrups, and combination drugs. The top formulation is EQUIRAB 1000IU/5ML [Rabies Antiserum-Equ with 6 shipments worth $300.0K.
How Does Bharat Serums AND Vaccines Limited Compare to Nearest Serum Exporters?
Exporters ranked immediately above and below #1 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | BHARAT SERUMS AND VACCINES LIMITED ★ | $6.5M | 131 | 29 | $50.0K |
| 2 | VINS BIOPRODUCTS LIMITED | $5.7M | 132 | 34 | $43.3K |
| 3 | PREMIUM SERUMS AND VACCINES PRIVATE LIMITED | $1.4M | 31 | 21 | $46.5K |
Bharat Serums AND Vaccines Limited ranks #1 among 341 Indian Serum exporters. Average shipment value of $50.0K compared to the market average of $54.1K. The closest competitors by value are VINS BIOPRODUCTS LIMITED and PREMIUM SERUMS AND VACCINES PRIVATE LIMITED.
Which Indian Ports Ship Serum Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 3,759 | 25.1% |
| SAHAR AIR | 2,925 | 19.5% |
| DELHI AIR | 2,682 | 17.9% |
| DELHI AIR CARGO ACC (INDEL4) | 1,589 | 10.6% |
| Bombay Air | 1,099 | 7.3% |
| Delhi Air | 546 | 3.6% |
| NHAVA SHEVA SEA (INNSA1) | 208 | 1.4% |
| HYDERABAD ACC (INHYD4) | 118 | 0.8% |
What Other Other Products Does Bharat Serums AND Vaccines Limited Export?
Bharat Serums AND Vaccines Limited also exports these other products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Bharat Serums AND Vaccines Limited's Serum Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like BSV. Heightened security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor have led major carriers to alter trade routes, resulting in extended transit times and increased freight rates on key India–Europe shipping lanes. These disruptions can impact the timely delivery of pharmaceutical products, potentially affecting supply chains and customer relationships. (livemint.com)
Conversely, the India–European Union Free Trade Agreement, concluded in January 2026, is poised to eliminate tariffs on Indian pharmaceutical exports to the EU. This development enhances the competitiveness of Indian exporters like BSV in the European market, potentially offsetting some of the logistical challenges posed by current shipping disruptions. (en.wikipedia.org)
Additionally, ongoing US-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, creating opportunities for Indian manufacturers to increase their market share in the US. BSV's established presence in critical care and biologics positions it well to capitalize on this shift.
Bharat Serums AND Vaccines Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for pharmaceutical exporters. BSV's adherence to stringent quality requirements, including FDA, WHO, and EU GMP standards, has been instrumental in maintaining its export credentials. The company's focus on high-entry-barrier products necessitates continuous investment in quality assurance and regulatory compliance to meet the evolving standards of global markets.
The recent acquisition by Mankind Pharma is expected to bolster BSV's compliance infrastructure, leveraging Mankind's resources to enhance quality systems and ensure sustained adherence to international regulatory expectations.
About Bharat Serums AND Vaccines Limited
Bharat Serums AND Vaccines Limited exports 4 products worth $40.1M. Beyond Serum, top products include Immunoglobulin, Amphotericin, Folic. View the complete Bharat Serums AND Vaccines Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Serum — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Serum shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Bharat Serums AND Vaccines Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 199 individual customs records matching Bharat Serums AND Vaccines Limited exporting Serum, covering 110 formulations to 33 countries via 74 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 122+ countries, 897+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Serum Export Data from Bharat Serums AND Vaccines Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Bharat Serums AND Vaccines Limited's Serum exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Bharat Serums AND Vaccines Limited
Full Company Profile →
4 products · $40.1M total trade · 3 categories
Serum Stats
Company Overview
Top Products by Bharat Serums AND Vaccines Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Bharat Serums AND Vaccines Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Serum. For current shipment-level data, contact TransData Nexus.